ATE361099T1 - Heilmittel für kachexie - Google Patents

Heilmittel für kachexie

Info

Publication number
ATE361099T1
ATE361099T1 AT98919584T AT98919584T ATE361099T1 AT E361099 T1 ATE361099 T1 AT E361099T1 AT 98919584 T AT98919584 T AT 98919584T AT 98919584 T AT98919584 T AT 98919584T AT E361099 T1 ATE361099 T1 AT E361099T1
Authority
AT
Austria
Prior art keywords
parathyroid hormone
related peptide
cachexia
remedies
inhibiting
Prior art date
Application number
AT98919584T
Other languages
English (en)
Inventor
Koh Chugai Sato
Toshiaki Tsunenari
Kimie Chugai Ishii
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE361099T1 publication Critical patent/ATE361099T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Valve Device For Special Equipments (AREA)
  • Confectionery (AREA)
  • Massaging Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymerisation Methods In General (AREA)
AT98919584T 1997-05-15 1998-05-13 Heilmittel für kachexie ATE361099T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12550597 1997-05-15
JP19444597 1997-07-18

Publications (1)

Publication Number Publication Date
ATE361099T1 true ATE361099T1 (de) 2007-05-15

Family

ID=26461935

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98919584T ATE361099T1 (de) 1997-05-15 1998-05-13 Heilmittel für kachexie

Country Status (19)

Country Link
US (2) US20020165363A1 (de)
EP (1) EP1004313B1 (de)
KR (1) KR100508338B1 (de)
CN (1) CN1329080C (de)
AT (1) ATE361099T1 (de)
AU (1) AU750021C (de)
BR (1) BR9809629A (de)
CA (1) CA2289910A1 (de)
DE (1) DE69837707T2 (de)
ES (1) ES2285769T3 (de)
HK (1) HK1029047A1 (de)
IL (1) IL132896A0 (de)
NO (1) NO995558L (de)
PL (1) PL193575B1 (de)
SK (1) SK155799A3 (de)
TR (1) TR199902800T2 (de)
TW (1) TWI227140B (de)
UA (1) UA74130C2 (de)
WO (1) WO1998051329A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK40599A3 (en) 1996-09-26 2000-06-12 Chugai Pharmaceutical Co Ltd Antibody against human parathormone related peptides
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2289910A1 (en) 1997-05-15 1998-11-19 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for cachexia
WO2001002011A1 (fr) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha REMEDES CONTRE LES MALADIES CAUSEES PAR PTH OU PTHrP
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
EP1987842A1 (de) * 2000-04-28 2008-11-05 Chugai Seiyaku Kabushiki Kaisha Zellproliferationshemmer
US20040067231A1 (en) * 2000-08-16 2004-04-08 Hideki Yoshikawa Agents for ameliorating symtoms caused by joint diseases
JP2003021631A (ja) * 2001-05-10 2003-01-24 Chugai Pharmaceut Co Ltd 骨転移抑制剤のスクリーニング方法
DOP2006000277A (es) 2005-12-12 2007-08-31 Bayer Pharmaceuticals Corp Anticuerpos anti mn y métodos para su utilización
ES2610607T3 (es) 2007-05-21 2017-04-28 Alderbio Holdings Llc Anticuerpos contra IL-6 y usos de los mismos
US8252286B2 (en) 2007-05-21 2012-08-28 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
US8178101B2 (en) 2007-05-21 2012-05-15 Alderbio Holdings Inc. Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
US8404235B2 (en) 2007-05-21 2013-03-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8062864B2 (en) 2007-05-21 2011-11-22 Alderbio Holdings Llc Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
US20090238825A1 (en) * 2007-05-21 2009-09-24 Kovacevich Brian R Novel rabbit antibody humanization methods and humanized rabbit antibodies
US7906117B2 (en) * 2007-05-21 2011-03-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
WO2009120836A1 (en) * 2008-03-26 2009-10-01 Neurosigma, Inc. Methods for identifying and targeting autonomic brain regions
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US8323649B2 (en) * 2008-11-25 2012-12-04 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US8420089B2 (en) 2008-11-25 2013-04-16 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US9452227B2 (en) 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US8337847B2 (en) 2008-11-25 2012-12-25 Alderbio Holdings Llc Methods of treating anemia using anti-IL-6 antibodies
US9724410B2 (en) 2009-11-24 2017-08-08 Alderbio Holdings Llc Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
CA2789125A1 (en) 2010-02-10 2011-08-18 Novartis Ag Methods and compounds for muscle growth
AU2011332817A1 (en) 2010-11-23 2013-06-13 Alder Biopharmaceuticals, Inc. Anti-IL-6 antibodies for the treatment of anemia
CN103327977B (zh) 2011-01-31 2016-05-04 东丽株式会社 恶液质的治疗或预防剂
JP6262721B2 (ja) 2012-05-11 2018-01-17 ジェムバックス アンド カエル カンパニー，リミティド 敗血症の予防用または治療用の組成物
CN108841802B (zh) 2012-05-11 2023-06-09 珍白斯凯尔有限公司 抗炎性肽及包含其的组合物
WO2014010971A1 (ko) 2012-07-11 2014-01-16 주식회사 카엘젬백스 세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물
KR102258864B1 (ko) 2013-04-19 2021-06-01 주식회사 젬백스앤카엘 허혈성 손상 치료 및 예방용 조성물
WO2014196841A1 (en) 2013-06-07 2014-12-11 Kael-Gemvax Co., Ltd. Biological markers useful in cancer immunotherapy
CN105324123B (zh) 2013-06-21 2022-02-08 珍白斯凯尔有限公司 激素分泌调节剂、包含该调节剂的组合物、和利用其控制激素分泌的方法
JP6382972B2 (ja) 2013-10-23 2018-08-29 ジェムバックス アンド カエル カンパニー，リミティド 前立腺肥大治療用及びその予防用の組成物
JP6553605B2 (ja) 2013-11-22 2019-07-31 ジェムバックス アンド カエル カンパニー，リミティド 血管新生抑制活性を有するペプチド、及びそれを含む組成物
ES2809251T3 (es) 2013-12-17 2021-03-03 Gemvax & Kael Co Ltd Composición para tratar cáncer de próstata
EP3130345B9 (de) 2014-04-11 2022-05-04 Gemvax & Kael Co., Ltd. Peptid mit fibrosehemmender wirkung und zusammensetzung damit
KR102232320B1 (ko) 2014-04-30 2021-03-26 주식회사 젬백스앤카엘 장기, 조직 또는 세포 이식용 조성물, 키트 및 이식 방법
KR102413243B1 (ko) 2014-12-23 2022-06-27 주식회사 젬백스앤카엘 안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
US10835582B2 (en) 2015-02-27 2020-11-17 Gemvax & Kael Co. Ltd. Peptide for preventing hearing loss, and composition comprising same
EP3318265B1 (de) 2015-07-02 2021-08-18 Gemvax & Kael Co., Ltd. Peptid mit antiviraler wirkung und zusammensetzung damit
CN109328068A (zh) 2016-04-07 2019-02-12 珍白斯凯尔有限公司 具有增加端粒酶活性和延长端粒的效果的肽以及包含该肽的组合物

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293130A3 (de) * 1987-05-26 1990-06-13 Merck & Co. Inc. Dimere von Parathyroid-Hormon-Antagonisten
US4771124A (en) * 1987-05-26 1988-09-13 Merck & Co., Inc. Parathyroid hormone antagonists with simplified synthetic methodology
EP0293158A3 (de) 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroide Hormon-Antagonisten
US5001223A (en) 1987-05-26 1991-03-19 Merck & Co., Inc. Parathyroid hormone antagonists with enhanced metabolic properties
JPH03504605A (ja) 1988-05-27 1991-10-09 セントカー・インコーポレーテツド 抗体産生物の凍結乾燥した配合物
EP0417191B1 (de) 1988-05-27 1993-03-10 Centocor, Inc. Formulierung für antikörper enthaltende reagenzien
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5217896A (en) * 1988-12-30 1993-06-08 Oncogene Science, Inc. Monoclonal antibodies recognizing parathyroid hormone-like protein
JPH02207099A (ja) 1989-02-07 1990-08-16 Tonen Corp ＰＴＨｒＰ関連ペプチド、その製造法及び用途
CA2035179C (en) 1990-01-31 2001-08-14 Gerald S. Brenner Pharmaceutical compositions containing insoluble salts of bisphosphonic acids
GB9009548D0 (en) 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method
JPH04228089A (ja) * 1990-05-15 1992-08-18 Kanegafuchi Chem Ind Co Ltd 高カルシウム血症治療・予防剤
CA2087190A1 (en) 1990-07-13 1992-01-14 Fred E. Cohen Parathyroid hormone analogues modified at positions
WO1992017602A1 (en) 1991-04-05 1992-10-15 The General Hospital Corporation Office Of Technology Affairs Parathyroid hormone receptor and dna encoding same
DK0628639T3 (da) 1991-04-25 2000-01-24 Chugai Pharmaceutical Co Ltd Rekonstitueret humant antistof mod human interleukin-6-receptor
DE69232669T2 (de) 1991-12-20 2003-02-27 Protein Design Labs, Inc. Mit gp11b/iiia reaktive humane antikörper
US5648267A (en) 1992-11-13 1997-07-15 Idec Pharmaceuticals Corporation Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
US5849695A (en) 1993-01-13 1998-12-15 The Regents Of The University Of California Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals
JP3504697B2 (ja) 1993-09-30 2004-03-08 株式会社先端生命科学研究所 ＰＴＨｒＰアンタゴニスト活性を有するポリペプチド及びそれを含むカルシウム代謝治療薬
JPH07316195A (ja) 1994-05-25 1995-12-05 Nippon Kayaku Co Ltd 新規なＰＴＨｒＰ関連ペプチド及びその用途
CO4410206A1 (es) * 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN
US5993817A (en) 1995-01-23 1999-11-30 Xenotech Method to ameliorate osteolysis and metastasis
US5626845A (en) * 1995-01-23 1997-05-06 Xenotech Incorporated Method to ameliorate osteolysis and metastasis
DK0813423T3 (da) * 1995-01-23 2002-07-22 Xenotech Inc Præparat til forebyggelse af osteolysis og metastase
ATE363289T1 (de) 1995-02-20 2007-06-15 Yukio Kato Heilmittel für arthrosis deformans und entzündliche gelenkerkrankungen
AU713222B2 (en) 1995-03-01 1999-11-25 Stryker Corporation Morphogen-induced dentine regeneration
CA2761116A1 (en) 1995-04-27 1996-10-31 Amgen Fremont Inc. Human antibodies derived from immunized xenomice
US5660826A (en) 1995-06-06 1997-08-26 The Regents Of The University Of California Therapeutic sepsis treatment using antagonists to PTHrP
DE69713485T2 (de) 1996-02-01 2003-01-30 Chugai Seiyaku K.K., Tokio/Tokyo Medikamente für die Behandlung oder Vorbeugung von Thrombocytopenie
SK40599A3 (en) 1996-09-26 2000-06-12 Chugai Pharmaceutical Co Ltd Antibody against human parathormone related peptides
JP4372240B2 (ja) 1997-05-15 2009-11-25 中外製薬株式会社 悪液質治療剤
CA2289910A1 (en) 1997-05-15 1998-11-19 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for cachexia
JP4414494B2 (ja) 1998-02-03 2010-02-10 旭化成ファーマ株式会社 白血球減少症の予防剤および治療剤
EP1075491B1 (de) 1998-05-05 2008-04-16 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Pth2 rezeptor selektive verbindungen
JP2000080100A (ja) 1998-06-17 2000-03-21 Japan Tobacco Inc 副甲状腺ホルモン関連タンパクに対するヒトモノクローナル抗体
EP1090643A4 (de) 1998-06-26 2004-05-26 Chugai Pharmaceutical Co Ltd Heilmittel für hyperkalzämische krise

Also Published As

Publication number Publication date
WO1998051329A1 (fr) 1998-11-19
TR199902800T2 (xx) 2000-04-21
ES2285769T3 (es) 2007-11-16
EP1004313A1 (de) 2000-05-31
EP1004313A4 (de) 2005-01-19
US7468184B2 (en) 2008-12-23
UA74130C2 (uk) 2005-11-15
PL193575B1 (pl) 2007-02-28
SK155799A3 (en) 2000-06-12
DE69837707D1 (de) 2007-06-14
PL336797A1 (en) 2000-07-17
AU750021C (en) 2003-10-16
CN1255858A (zh) 2000-06-07
BR9809629A (pt) 2000-07-04
EP1004313B1 (de) 2007-05-02
AU7236998A (en) 1998-12-08
US20020165363A1 (en) 2002-11-07
CN1329080C (zh) 2007-08-01
KR100508338B1 (ko) 2005-08-17
TWI227140B (en) 2005-02-01
NO995558D0 (no) 1999-11-12
AU750021B2 (en) 2002-07-11
NO995558L (no) 2000-01-12
US20030138424A1 (en) 2003-07-24
IL132896A0 (en) 2001-03-19
CA2289910A1 (en) 1998-11-19
DE69837707T2 (de) 2008-01-10
KR20010012613A (ko) 2001-02-15
HK1029047A1 (en) 2001-03-23

Similar Documents

Publication Publication Date Title
ATE361099T1 (de) Heilmittel für kachexie
DK1108435T3 (da) Forebyggende midler eller midler mod pancreatitis indeholdende anti-IL-6-receptor-antistoffer som den aktive bestanddel
AU5732101A (en) Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
DE60229435D1 (de) Kondensierte heterocyclische succinimidverbindungen und deren analoga, modulatoren der funktion von nukleären hormonrezeptoren
WO2003028582A3 (en) Bovine pregnancy test
WO2003002717A3 (en) Biological activity of ak155
ITRM940805A0 (it) Metodo per selezionare superagonisti, antagonisti e superantagonisti di ormoni del cui complesso recettoriale fa parte gp 130
TR200003768T2 (tr) Hiperkalsemik krizler için terapötik aktif madde.
DE69837387D1 (de) (d)-METHADON, EIN NICHT-OPIOIDES SCHMERZMITTEL
EP1029916A4 (de) Menschlicher lysophosphatidsäure rezeptor und dessen verwendung
EP1567178A4 (de) Modulatoren von rezeptoren für nebenschilddrüsenhormon- und nebenschildsrüsenhormonbezogene proteine
BR9807682B1 (pt) composto, uso do mesmo, composiÇço farmacÊutica, e, processos para preparar um composto.
DK0810883T3 (da) Konjugat indeholdende DTPA og albumin til individuel dosering af lægemidler
DK1044064T3 (da) Overtrækningsindretning til granula til indtagelse ad oral vej
NO306113B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
FI974634A (fi) Laite materiaalin syöttämiseksi
WO2003073107A3 (en) Neuropeptide receptor and uses thereof
AU2001255537A1 (en) Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
HU0100948D0 (en) Antibody competiton binding assay for qualitative detection of the conformation changes and conformation-dependent quantitative detection of glycoprotein p and other cell surface receptors, pumps and proteins, and use thereof
FR2759296B1 (fr) Complexe non-covalent comprenant au moins un anticorps et un element de liaison aux immunoglobulines associe a une substance active, son procede de preparation et ses applications
ATE332924T1 (de) Peptidfragment der ligandenbindungstasche des östrogenrezeptors 3 (err3), kristallstrukturen davon, und deren verwendung
WO2001048483A3 (en) Method for screening of appetite control agents
DK31589A (da) Assay for begyndende diabetes, monoklonale antistoffer til anvendelse herved og saet til anvendelse hertil.
ZA200208518B (en) Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein.
ES1038384Y (es) Dispositivo vibrador para arboles.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties